SLCB050 is a compound with anticancer activity that inhibits the interaction between DX2 and p14/ARF. It decreases the viability of human lung cancer cells, particularly small cell lung cancer cells, in a p14/ARF-dependent manner, and induces cell apoptosis (apoptosis) and senescence.
Molekulargewicht:
366.36
CAS Nummer:
[1848971-16-3]
Formel:
C21H18O6
Target-Kategorie:
Apoptosis
T200005
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten